• Question: Measures of myocardial deformation, including global longitudinal strain and strain rate measured by intraoperative transesophageal echocardiography, are robust indicators of myocardial function, but can these measures predict postoperative outcomes? • Findings: Global longitudinal strain rate and global longitudinal strain were useful predictors of prolonged hospitalization (>7 days) in patients having aortic valve replacement.
M yocardial dysfunction increases the risk of mortality and morbidity after cardiac surgery 1, 2 ; accurate assessment may thus enhance perioperative risk stratification. The most common measure of myocardial function, the left ventricular ejection fraction (LVEF), evaluates changes in left ventricular chamber volume during the cardiac cycle without directly measuring myocardial muscle contraction, and thus cannot detect subtle contractile dysfunction. In contrast, left ventricular peak global longitudinal strain (GLS), a measure of myocardial deformation, directly measures the amount of myocardial longitudinal shortening and can detect subclinical myocardial dysfunction, even when it is not apparent by conventional echocardiography. 3 Left ventricular peak global longitudinal strain rate (SR), which assesses rate of change in strain, is another robust measure of myocardial contractility. GLS and SR, which provide robust, validated, quantitative echocardiographic measures of left ventricular systolic function, 3, 4 may improve preoperative risk stratification, especially in patients with myocardial or valvular diseases, such as aortic stenosis, where LVEF is often preserved. 5, 6 GLS predicts long-term outcomes, including mortality and major cardiac events, in nonsurgical patients with aortic stenosis. 7, 8 But only a few investigations considered myocardial deformation as predictors of adverse outcomes after cardiac surgery, and even fewer utilize intraoperative GLS or SR measured by transesophageal echocardiography (TEE). Whether intraoperative GLS or SR predicts early postoperative outcomes in patients with aortic stenosis having aortic valve replacement (AVR) surgery remains unknown.
The primary aim of this investigation was thus to quantify the association of worsening intraoperative GLS with postoperative outcomes in patients having AVR. The outcomes we evaluated were the need for postoperative inotropic/vasopressor support, prolonged hospitalization (>7 days), and postoperative atrial fibrillation. Secondarily, we also examined the association between SR and LVEF and these adverse postoperative outcomes.
METHODS
We report a post hoc analysis of prospectively collected data from a previously reported randomized trial titled, "Effect of hyperinsulinemic normoglycemia on myocardial function and utilization of glucose" (Clinical Trials. gov #NCT01187329). 9 This study was approved by the Cleveland Clinic Institutional Review Board, and written consent was obtained from participating patients. All patients enrolled in the primary analysis were considered for inclusion into this secondary analysis. This report complies with guidelines established by the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.
Briefly, the primary investigation randomly assigned patients scheduled for elective AVR between January 2011 and August 2013 to intraoperative glucose control using hyperinsulinemic normoglycemia (high-dose insulin infusion with concomitant variable exogenous glucose infusion aimed at target glucose concentration of 80-110 mg/dL) versus standard glucose control (insulin infusion if blood glucose >150 mg/dL during or after cardiopulmonary bypass). 9 Standardized TEE examination was conducted to evaluate myocardial function immediately after induction of anesthesia. Because the primary investigation demonstrated no meaningful difference in myocardial function measured by GLS and SR at baseline or after the intervention, both groups were combined for this subinvestigation.
The primary investigation included patients who were 40-84 years old presenting for elective AVR with or without coronary artery bypass grafting (CABG) surgery ± minor procedure (including Maze or pulmonary vein isolation, closure of patent foramen ovale, left atrial appendage ligation, septal myectomy, or tricuspid valve repair). Patients with aortic insufficiency without severe aortic stenosis, those with a contraindication for TEE or poor-quality echocardiographic images (>3 unacceptable myocardial segments in speckle-tracking echocardiographic analysis), and those requiring intraoperative hypothermic circulatory arrest were excluded. Of 100 patients enrolled in the primary investigation, 2 patients with contraindications to TEE and 3 patients with aortic insufficiency as the primary valvular pathophysiology were thus not included. Echocardiographic images were unacceptable in an additional 9 patients for GLS analysis and 11 patients for SR analysis (Figure 1 ).
Anesthetic and Surgical Management
Standard anesthesia monitors were supplemented by intraarterial catheters, central venous or pulmonary artery catheters, and TEE. Anesthetic induction involved administration of etomidate, fentanyl, and/or midazolam, and a depolarizing or nondepolarizing muscle relaxant. Anesthesia was subsequently maintained with fentanyl, isoflurane, and nondepolarizing muscle relaxants. Surgery was performed through either a full midline sternotomy or a minimally invasive upper hemisternotomy. Cardiopulmonary bypass and intermittent antegrade with or without retrograde blood cardioplegia were used. In all cases, a bioprosthetic valve replacement was inserted. Routine strategies for heparinization and initiation and separation from cardiopulmonary bypass were followed. Epinephrine and/or milrinone were given after separation from cardiopulmonary bypass when cardiac index was <2.0 L/min/m 2 despite preload optimization. Norepinephrine was given when myocardial performance was adequate (cardiac index ≥2.0 L/min/m 2 ) but systolic blood pressure was <90 mm Hg or systemic vascular resistance was <800 dynes-s/cm 5 . 
Conventional Echocardiographic Data Collection and Analysis

Assessment of Myocardial Deformation Using
Speckle-Tracking Echocardiography TEE images from the midesophageal level captured at equally spaced transducer angles of 60° (0°, 60°, and 120°) with frame rates between 40 and 90 Hz were used for analysis of myocardial deformation. GLS and SR were calculated off-line using speckle-tracking echocardiography software (EchoPAC v.112; GE Healthcare Vingmed Ultrasound AS, Horten, Norway) as previously described. 9 Briefly, speckletracking analysis of each 2D TEE image involved tracing the endocardial border on an end-systolic cavitary frame. The strain analysis software program then performed frame-to-frame tracking of myocardial deformation to calculate global and segmental longitudinal strain and SR. The software allows manual adjustment of automated LV tracking to improve accuracy. For each analysis, speckle tracking of LV myocardial segments was deemed as either "acceptable" or "unacceptable" by the software analysis program; however, the investigator (A.E.D.) was permitted to override this designation based on visual confirmation of acceptable tracking. GLS was calculated as the average of 6 myocardial segments from 3 echocardiographic views (a total of 18 myocardial segments). Only patients with 15 or more segments deemed acceptable by the software and/or the investigator were included in the GLS and SR analyses. This strategy is supported by evidence from our previous report where accurate and reproducible results were achieved when global measurements of 15 or more myocardial segments were assessed. 9 Our report adheres to the convention of referring to the absolute value of GLS/ SR when describing changes in myocardial deformation. 10 Analysis of myocardial deformation was performed by a single investigator (A.E.D.).
Outcome Measures
Postoperative inotropic/vasopressor support was defined as a low cardiac output state or low blood pressure (cardiac index <2.0 L/min/m 2 , systolic blood pressure <90 mm Hg, or systemic vascular resistance <800 dynes-s/cm 5 ) requiring pharmacologic hemodynamic support with epinephrine, norepinephrine, or milrinone after separation from cardiopulmonary bypass and continuing until intensive care unit admission or longer.
New-onset atrial fibrillation was defined as a postoperative occurrence of atrial fibrillation requiring treatment (antiarrhythmic therapy, rate-control therapy, or cardioversion) in patients without previous history of atrial dysrhythmias. Prolonged hospitalization was defined as hospitalization of >7 days after surgery. Hospital readmission was defined as a requirement for readmission to the hospital for any cause within 30 days after surgery.
Our prespecified primary outcome was a composite of postoperative inotropic/vasopressor support, postoperative new-onset atrial fibrillation, prolonged hospitalization (>7 days), and 30-day all-cause hospital readmission. However, the incidences of the individual end points varied considerably (ie, 44%, 35%, 26%, and 2%, respectively), which adversely affected statistical modeling; thus, we did not assess them as a collapsed composite outcome (any versus none) as planned. In addition, 30-day all-cause readmission was not analyzed due to its low incidence. Instead, we assessed the association between intraoperative GLS and the remaining 3 individual end points (postoperative inotropic/ vasopressor support, new-onset atrial fibrillation, and prolonged hospitalization).
Statistical Methods
Primary Analysis. The associations between intraoperative GLS and the outcomes (postoperative requirement for inotropic/vasopressor support, postoperative new-onset atrial fibrillation, and prolonged hospitalization [>7 days]) were each assessed using a multivariable logistics regression model. Due to the limited sample size, we adjusted for the following 4 potential confounders specified a priori in the analyses: (1) randomization groups (hyperinsulinemic normoglycemia versus standard glucose management); (2) age; (3) duration of cardiopulmonary bypass; and (4) concomitant CABG.
Statistical adjustment for randomization group was needed because patients received a different intraoperative therapy (hyperinsulinemic normoglycemia/standard glucose management) according to group assignment, which may have unknowingly influenced the outcomes. The other confounding variables were selected a priori because they represent clinically relevant factors that impact postoperative outcomes. Advanced age increases risk of mortality and prolonged hospitalization. 11 Duration of cardiopulmonary bypass independently predicts postoperative morbidity and mortality. 12 Concomitant CABG is associated with increased risk of adverse outcomes, including mortality, after AVR. 13, 14 Severe left ventricular hypertrophy as assessed by echocardiographic left ventricular mass index using the method of Devereux et al 15 is a predictor for 2-year mortality after AVR and was prespecified as a potential confounder 16 ; however, it was not included in the model due to large missing rate (10%). Only 2 patients were readmitted to a hospital within 30 days, which was not enough for statistical modeling and so association with this outcome was not evaluated.
Secondary Analysis. The associations between intraoperative SR and LVEF and each of the 3 outcomes were assessed using separate multivariable logistic regressions (a total of 6 analyses), adjusting for randomized group (hyperinsulinemic normoglycemia versus control), age, duration of cardiopulmonary bypass, and CABG procedure. Ten times of original peak longitudinal SR scales was modeled. We assessed the predictive ability of GLS, SR, and LVEF for predicting the 3 outcomes using receiver operating characteristic analysis and estimating the area under the curve (AUC) with standard error.
For informational purposes, we descriptively compared all the outcomes as well as inotropic agents between patients who had normal LVEF (>50%) and absolute value of GLS ≥−17% and patients who had normal LVEF and absolute value of GLS <−17%, using standard summary statistics and absolute standardized difference (ASD). Because postoperative inotropic support may increase the incidence of postoperative atrial fibrillation, 17 we descriptively compared the incidence of atrial fibrillation in patients who did and did not receive inotropic support. ASDs are the absolute difference in means or proportions divided by the pooled standard deviation. An ASD of 0.2, 0.5, and 0.8 represents small, medium, and large standardized differences, respectively.
Finally, we examined intraobserver variability of the speckle-tracking analysis using Lin's concordance correlation, Bland-Altman limits of agreement, and the binomial exact method.
A Bonferroni correction was used to adjust for multiple testing, with a significance criterion of P < .017 used for each primary analysis (ie, 0.05/3) and P < .008 used for each secondary analysis (ie, 0.05/6).
Post Hoc Sensitivity Analysis. Because the sample size limited the number of confounding variables included in our analysis, we were only able to adjust for the most important potential confounders (defined a priori). Because reoperative surgery is an important potential confounder that was excluded from the original analysis, we performed post hoc sensitivity analyses to confirm the association between GLS, SR, and LVEF and the outcomes adjusting for reoperative surgery instead of randomization group. In addition, 3 patients who had mitral valve surgery were excluded. We completed the post hoc sensitivity analyses using the same methods as used for the primary and secondary analyses.
Power Analysis. We included all the available patients from a previously reported randomized trial. 9 Power was estimated from a univariable logistic regression model (ie, without covariables) assuming that GLS is normally distributed with a mean ± standard deviation of −17 ± 4 and using the observed incidence of 44%, 35%, and 26% for inotropic/vasopressor support, atrial fibrillation, and prolonged hospitalization, respectively. We estimated that, with 86 patients included in the primary analyses, we would have sufficient power (>90%) at the 0.017 significance level to detect an odds ratio per 1% change in GLS of 1.26 or more for postoperative inotrope/vasopressor support, 1.27 or more for postoperative atrial fibrillation, and 1.29 or more for prolonged hospitalization.
SAS software version 9.4 (SAS Institute, Cary, NC) was used for all statistical analyses.
RESULTS
Of 86 patients with aortic stenosis who had AVR and met eligibility criteria (Figure 1 ), 43 patients received hyperinsulinemic normoglycemic clamp treatment and 40 patients had CABG procedure. Additional procedures were performed in 18 patients (21%) included minor procedures (n = 7), aortoplasty (n = 5), ascending aorta replacement (n = 5), mitral valve repair (n = 2), or replacement (n = 1). Demographics, patient comorbidities, and other intraoperative factors for all included patients are shown in Table 1 .
Primary Analyses
The observed mean ± standard deviation of intraoperative GLS was −17% ± 4%. We found that decreased (absolute value) intraoperative GLS was associated with prolonged hospitalization (>7 days), after adjusting for predefined confounders. The estimated odds of having prolonged hospitalization was 1.22 times more likely (98.3% confidence interval [CI], 1.01-1.47) per 1% worsening of GLS (P = .012). However, GLS was neither associated with postoperative inotropic/vasopressor support (P = .05, which was greater than the prespecified significance criterion of 0.017) nor postoperative atrial fibrillation (P = .79) (Figure 2 , Supplemental Digital Content, Appendix in SR; P = .003). However, it was neither associated with postoperative atrial fibrillation (P = .43) nor postoperative inotropic/vasopressor use (P = .04, which was greater than the prespecified significance criterion of 0.008) (Figure 2 , Supplemental Digital Content, Appendix Table A, http:// links.lww.com/AA/C145). Mean ± standard deviation of LVEF was 62% ± 12% for the 95 patients with available measurements. LVEF was not associated with any of the 3 outcomes (Figure 2 , Supplemental Digital Content, Appendix Table A, http://links.lww.com/AA/C145). Note that the odds ratios for GLS and SR are in opposite directions compared with LVEF because more negative GLS and SR represent improved myocardial function, while the opposite (more positive) is true for LVEF. The AUCs depicting predictive ability for GLS, SR, and LVEF for all outcomes are shown in Figure 3 .
As shown in Table 2 , patients who had normal LVEF and GLS (absolute value) ≥17%, on average, were less likely to require epinephrine (ASD >0.5) compared with patients with normal LVEF and abnormal GLS (absolute value) <17%. No patients required milrinone.
Atrial fibrillation occurred in 13 (38%) of patients who received inotropic support and 21 (62%) who did not receive inotropic support. Atrial fibrillation did not differ between GLS cutoff values.
Assessment of intraobserver agreements between the first and secondary readings of LV strain and SR was excellent, with the Lin's concordance correlation (95% CI) of 0.94 (0.87-0.98) for GLS, and 0.93 (0.85-0.97) for SR. BlandAltman limits of agreement and the binomial exact method demonstrated good to excellent intraobserver agreement as previously described. 9 
Post Hoc Sensitivity Analysis
The results of our post hoc sensitivity analyses were similar to the original primary and secondary analyses that were designed a priori. While not statistically significant, the estimated odds of prolonged hospitalization (>7 days) were 1.24 times more likely (98.3% CI, 0.997-1.55) per 1% worsening of GLS (P = .018; P < .017 required for statistical significance 
DISCUSSION
We examined whether measures of myocardial deformation provide clinically relevant prognostic information for postoperative complications after AVR. We report that GLS and SR were associated with prolonged hospitalization and may be stronger predictors for this outcome than conventional echocardiographic measures, specifically LVEF.
GLS is especially useful as a measure of myocardial function in patients with aortic stenosis since longitudinal strain worsens as severity of aortic stenosis-despite a preserved LVEF. 18 Certainly, asymptomatic patients with aortic stenosis experience early impairment of LV longitudinal, but not radial, muscle fiber contraction. 19, 20 Subclinical myocardial dysfunction related to fibrosis of the hypertrophied myocardium is thus easily detected by GLS and SR. 21 Subclinical myocardial dysfunction may explain, at least in part, why more pronounced left ventricular hypertrophy is associated with increased mortality and morbidity after AVR. 22 Few reports examine the ability of measures of myocardial deformation assessed by intraoperative TEE to predict postoperative outcomes. Although GLS measured by transthoracic echocardiography predicts long-term mortality and major cardiac events in nonsurgical patients with aortic stenosis, 7, 8, 18, 19, 23 only a few investigations examine outcomes after cardiac surgery. GLS predicted postoperative mortality, myocardial dysfunction, and the need for prolonged inotropic support in cardiac surgical patients, although GLS was measured preoperatively by transthoracic echocardiography. 24, 25 One report used intraoperative GLS measured by TEE and reported that severe LV dysfunction predicted death, need for mechanical circulatory support, or high-dose inotropic support after cardiac surgery. 26 We are not aware Other procedures included Maze or pulmonary vein isolation (n = 3), left atrial appendage ligation (n = 1), tricuspid valve repair (n = 2), aortoplasty (n = 5), ascending aorta replacement (n = 5), mitral valve repair (n = 2), mitral valve replacement (n = 1), and septal myectomy (n = 1).
of other reports, however, that examine intraoperative TEEmeasured GLS and SR to predict outcomes after cardiac surgery. Our report thus uniquely demonstrates the potential for useful application of intraoperative GLS and SR measured by TEE in patients having AVR and reports an important association between myocardial deformation and prolonged hospitalization. Every 1% worsening in GLS increased the risk of prolonged hospitalization by 22%, and every 10th unit worsening in SR increased the risk of prolonged hospitalization by nearly 70%. Thus, use of GLS and SR may improve perioperative risk stratification and resource utilization. We expected to find a significant association between GLS and the need for postoperative inotropic/vasopressor support. Our results, however, demonstrated no association for several reasons. First, our sample size was relatively small, and the analysis was underpowered. Second, we adjusted for multiple comparisons, and the conservative prespecified criteria for significance was not reached. Third, our prespecified outcome included the combined use of inotropic and vasopressor support; however, an association between GLS and the need for inotropic support (without vasopressor use) may have been more clinically relevant. Use of epinephrine was higher in patients with worse GLS, and inclusion of vasopressor use diluted this effect resulting in a nonsignificant association.
Although reports examining GLS to predict outcomes in surgical and nonsurgical setting are increasing, few assess the clinical utility of SR. SR is a well-established measure of LV contractility that correlates with the rate of LV pressure rise (dP/dt) 27 and detects improved myocardial function even when strain is unchanged. 28, 29 Importantly, SR is less affected by changes in loading conditions and heart rate than GLS [30] [31] [32] and may thus provide a more robust measure of LV function. SR, however, is more difficult to measure because of substantial noise and variability in SR curves, challenges with interpretation, and increased risk of measurement error by inexperienced users. Further development in software analysis programs may simplify Figure 2 . Odds ratios of each outcome for 1% decrease (absolute value) in the intraoperative left ventricular GLS, a 0.1% decrease (absolute value) in global longitudinal SR, and 10% increase in LVEF were plotted. We adjusted for multiple testing by Bonferroni correction. Correspondingly, P values <.017 were considered significant for the primary outcome GLS (98.3% CIs were plotted), and P values <.008 were considered significant for the secondary outcomes of SR and LVEF (99.2% CIs were plotted). The box represents the odds ratio, and the line represents the CI. CI indicates confidence interval; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; SR, strain rate.
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and promote the use of SR in the clinical setting. Certainly, SR remains one of the few measures that can assess the rate of myocardial contraction. 4, 31, 33, 34 SR had higher predictability for prolonged hospitalization compared with GLS and LVEF, but SR did not predict the use of inotropic support for the same reasons detailed above for GLS, including small sample size, conservative adjustment for multiple comparisons, and confounding with vasopressor use. Our investigation supports the clinical usefulness of SR as a stronger predictor of prolonged hospitalization than GLS and LVEF.
Because LVEF is preserved by left ventricular hypertrophy until late stages of aortic stenosis, LVEF cannot identify patients with subclinical myocardial dysfunction. We descriptively explored whether patients with normal LVEF (LVEF >50%) and normal GLS were different than patients with normal LVEF and abnormal GLS (worse than −17%). Nearly half of the patients with normal LVEF had abnormal strain, and many differences were evident between patients with normal versus abnormal GLS, most notably epinephrine use. GLS may improve predictive ability in this subpopulation; however, further research is needed.
This investigation compared the predictive ability of GLS and SR to the most common clinical measure, LVEF. GLS and SR were significantly associated with prolonged hospitalization, while LVEF was not (although partly due to adjustment for multiple comparisons). However, when compared with the receiver operating characteristic curves, SR had the highest predictability, followed by GLS, and finally LVEF. An AUC of SR (0.72), however, provides only moderate predictability-consistent with the fact that multiple perioperative factors affect length of hospitalization.
Decreased GLS predicts atrial fibrillation in nonsurgical diabetic patients, 35 after acute myocardial infarction, 36 and after AVR. 37 We examined whether decreased GLS or SR was associated with increased risk of atrial fibrillation and found no association. Our patient population may have differed from previous reports because the mean GLS in our patient population was near normal at −17.0%, while others 37 reported a worse mean strain of −14.2%. Fewer patients with abnormal GLS in our study may have compromised the ability to predict postoperative atrial fibrillation. Our results likely reflect the multifactorial etiology of postoperative atrial fibrillation: other risk factors may overpower an effect of subtle decrements in myocardial function measured by GLS or SR. Our results are comparable to other large retrospective investigations which found that myocardial function assessed by LVEF was only a weak predictor of postoperative atrial fibrillation. 38, 39 Our investigation provides evidence that longitudinal measures of myocardial deformation, specifically GLS and SR, predict outcomes after AVR for aortic stenosis. However, whether these results can be extrapolated to patients with aortic insufficiency are unclear, due to differences in valvular pathophysiology and strain parameters. For instance, increased afterload seen in aortic stenosis impairs longitudinal and circumferential strain while sparing radial strain 20 ; in contrast, all 3 components of strain are affected with aortic insufficiency. 40 Further, patients with aortic stenosis experience an improvement in longitudinal and radial measures of myocardial deformation after AVR, 41, 42 while those with aortic insufficiency experience decreased radial strain, possibly related to reduced ventricular preload. 43 These data suggest that our results cannot be directly extrapolated to patients with aortic insufficiency having AVR. Similar concerns may be considered in patients with mitral valve disease having mitral valve replacement.
Our prespecified study design examined the association between GLS and a composite outcome; however, large differences in the incidences of each outcome forced us to evaluate the association with each outcome individually, although we conservatively adjusted for multiple comparisons to reduce the risk of type I error. We were unable to examine the association between hospital readmission and GLS/SR because of the low incidence of hospital readmission. Although we report a significant association between GLS and SR with risk of prolonged hospitalization, our investigation was underpowered to detect an association between measures of myocardial deformation and the use of inotropic/vasopressor medications.
Due to our small sample size, we were only able to adjust for the 4 potential confounding variables that we considered most important a priori to maintain model stability. Therefore, results may be influenced by demographics, comorbidities, or other patient and surgical characteristics that we could not adjust for. Also, the effect of aortic regurgitation, which was seen in a small number of patients, on postoperative GLS and SR could not be examined. We performed a post hoc sensitivity analysis to further confirm the relationship between measures of myocardial deformation and the outcomes, and found remarkably similar results. Although GLS just missed statistical significance (P = .018, P < .017 was the significance criterion), the odds ratio was slightly stronger (1.24 vs 1.22) although the CIs were wider, likely related to a reduced sample size. We interpret the results of this post hoc analysis as supporting our initial conclusions that reduced myocardial deformation is associated with prolonged hospitalization. Future research with a larger sample size and more comprehensive adjustment for potential confounders is required to confirm the associations between GLS, SR, and LVEF with outcomes.
It is possible that the occurrence of atrial fibrillation in our cohort was influenced by postoperative inotropic use. Although we could not statistically adjust the incidence of atrial fibrillation for inotropic use since both were coprimary outcomes, the incidence of atrial fibrillation was not greater in patients who received inotropic support, suggesting that perioperative inotropic support did not promote atrial fibrillation in our investigation. GLS measured after CPB may also predict outcomes; however, it was not included in our analysis since it occurred after one of the coprimary outcomes (inotropic/vasopressor medication use) was measured.
Combined use of inotropic and vasopressor medications diluted the association with measures of myocardial deformation. Patients often have an AVR before significant impairment in GLS occurs, as suggested by the near-normal median GLS of our study cohort, and this limited range of GLS may be inadequate to detect an association between myocardial deformation and outcomes. Measurements of myocardial deformation, including GLS/SR, have not been standardized and thus measures made with echocardiography machines from other vendors may differ. 10 Although our investigation identified an association between measures of myocardial deformation and prolonged hospitalization, the overall association was only moderate at best, which is expected because outcomes like atrial fibrillation or prolonged hospitalization are multifactorial in origin, and are not solely influenced by myocardial function.
In conclusion, our investigation examined whether intraoperative GLS predicted postoperative adverse outcomes. We report that GLS, along with SR, predicted prolonged hospitalization in patients with aortic stenosis having AVR. These predictors were not associated with postoperative inotropic/vasopressor support or postoperative atrial fibrillation. Therefore, our report provides evidence that GLS and SR measured by intraoperative TEE provide clinically relevant measures of myocardial function. E
